Methyl acetylsalicylate

CAS No. 580-02-9

Methyl acetylsalicylate( ACETYLSALICYLIC ACID METHYL ESTER )

Catalog No. M24571 CAS No. 580-02-9

Methyl acetylsalicylate is a natural product isolated from Pisum sativum. Inhibition of collagen-induced human platelet rich plasma aggregation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 28 In Stock
200MG Get Quote In Stock
500MG 63 In Stock
1G 95 In Stock

Biological Information

  • Product Name
    Methyl acetylsalicylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl acetylsalicylate is a natural product isolated from Pisum sativum. Inhibition of collagen-induced human platelet rich plasma aggregation.
  • Description
    Methyl acetylsalicylate is a natural product isolated from Pisum sativum. Inhibition of collagen-induced human platelet rich plasma aggregation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ACETYLSALICYLIC ACID METHYL ESTER
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    580-02-9
  • Formula Weight
    194.18
  • Molecular Formula
    C10H10O4?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC(=O)OC1=CC=CC=C1C(=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Goodyeroside A

    Goodyeroside A is a glycoside compound derived from the plant Goodyera that exhibits significant hepatoprotective activity. It can inhibit liver damage induced by carbon tetrachloride in primary cultured rat hepatocytes.

  • Methyl 2,6-dichlorob...

    Methyl 2,6-dichlorobenzoate is a biochemical compound that is used for proteomics research.

  • RMC-7977

    RMC-7977 is a highly selective inhibitor of the active (GTP-bound) forms of KRAS, HRAS, and NRAS with anticancer activity for the study of solid tumors with KRAS G12C mutations.